Virksomhedsstatus | NORMAL. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 16.01.1956 (25048
dage). |
Ingen historik.
Branche | Engroshandel med medicinalvarer og sygeplejeartikler (464610). |
Sidst opdateret den 16.06.2017 og
angivet som gældende fra 02.01.2017 (2781
dage). |
Historik | Start | Stop |
---|
Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 02.01.2017 | |
Fremstilling af andre fødevarer i.a.n (108900) | 01.01.2017 | 01.01.2017 |
Engroshandel med medicinalvarer og sygeplejeartikler (464610) | 01.01.2008 | 31.12.2016 |
Engroshandel med medicinalvarer og sygeplejeartikler (514610) | 01.05.2007 | 31.12.2007 |
Engroshandel med parfumerivarer og kosmetik (514500) | 21.12.2006 | 30.04.2007 |
Engroshandel med medicinalvarer og sygeplejeartikler (514610) | 16.01.1956 | 20.12.2006 |
Revisionfravalgt | false. |
Sidst opdateret den 11.03.2015 og
angivet som gældende fra 04.10.2001 (8350
dage). |
Ingen historik.
Revisor | KPMG P/S |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 12.09.2014 (3624
dage). |
Ingen nuværende registrering.
Ingen historik.
Telefonnummer | 44201100. |
Sidst opdateret den 01.04.2000 og
angivet som gældende fra 23.01.2000 (8970
dage). |
Ingen historik.
Navne | PFIZER ApS. |
Sidst opdateret den 04.10.2001 og
angivet som gældende fra 27.09.2001 (8357
dage). |
Historik | Start | Stop |
---|
PFIZER ApS | 27.09.2001 | |
PFIZER A/S | 16.01.1956 | 26.09.2001 |
Binavne | PFIZER PFE ApS. |
Sidst opdateret den 01.11.2021 og
angivet som gældende fra 01.11.2021 (1017
dage). |
Historik | Start | Stop |
---|
PFIZER PFE ApS | 01.11.2021 | |
ACO ApS | 04.10.2001 | |
KABI PHARMACIA ApS | 04.10.2001 | |
KABI PHARMACIA OPERATIONS ApS | 04.10.2001 | |
MONSANTO DANMARK ApS | 04.10.2001 | |
PFIZER CONSUMER HEALTHCARE ApS | 04.10.2001 | |
PHARMACIA ApS | 04.10.2001 | |
PHARMACIA DANMARK ApS | 04.10.2001 | |
PHARMACIA ELECTRONICS ApS | 04.10.2001 | |
PROBETA ANPARTSSELSKAB | 04.10.2001 | |
HOWMEDICA A/S | 16.01.1956 | 05.04.1995 |
Tegningsregel | Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør. |
Sidst opdateret den 09.02.2015 og
angivet som gældende fra 01.05.2014 (3758
dage). |
Fortolkning
(2 tegningsmuligheder)
| 2 bestyrelsesmedlemmer + |
1 bestyrelsesmedlem + 1 direktør |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMG Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class C, large enterprise
Grundlag for konklusion (revision):BasisforopinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionWe have audited the financial statements of Pfizer ApS for the financial year 1 December 2022 – 30 November 2023 comprising income statement, balance sheet, statement of changes in equity and notes. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 30 November 2023 and of the results of the Company's operations for the financial year 1 December 2022 – 30 November 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):StatementontheManagement'sreviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review
Historik | Start | Stop |
---|
Engroshandel med medicinalvarer og sygeplejeartikler | 01.01.2017 | 01.01.2017 |
Fremstilling af andre fødevarer i.a.n | 18.12.2013 | 31.12.2016 |
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.